ITMC - Itoco Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.6000
+0.0135 (+2.31%)
At close: 3:52PM EDT
Stock chart is not supported by your current browser
Previous Close0.5865
Open0.5450
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.5450 - 0.6150
52 Week Range0.0500 - 0.9000
Volume62,474
Avg. Volume208,689
Market Cap63,670
Beta (3Y Monthly)-5.41
PE Ratio (TTM)N/A
EPS (TTM)-0.0200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRE

    ITOCO Enters Into A Commercial Alliance With Innova Group SAS Colombia For The Cultivation Of CBD Cannabis

    TORONTO, ON / ACCESSWIRE / September 17, 2019 / ITOCO Inc. ("ITOCO" or the "Company") (OTC PINK:ITMC) is pleased to announce that it has made a strategic expansion in Colombia by entering into a LETTER OF INTENTION with CANNABIS MEDICAL INNOVA GROUP SAS to carry out a commercial alliance. ITOCO has been established in Bogota since 2015, making it one of the more mature medical cannabis companies in Colombia. ITOCO is building a platform with the potential to produce significant volumes of Cannabidiol (CBD) isolate and other extracted products via a series of Joint Ventures and business alliances with established local Colombian license holders and landowners.

  • ACCESSWIRE

    Itoco Completes Review Of Best-Practice Technologies And Methodologies For High-Quality CBD Oil Extraction

    TORONTO, CANADA / ACCESSWIRE / August 20, 2019 / ITOCO Inc. ("ITOCO" or the "Company") (OTC PINK:ITMC) is pleased to announce that it has recently completed a review of the state of the art for technologies and methodologies as it pertains to extracting CBD oil from Cannabis plant matter. The subjects of this review ranged from solvents and temperatures to use in the initial extraction wash, to different filtration methods and options, to distillation and/or purification methods and technologies. An internal recommendation for technologies and methodologies has been reached and shared with the management team and this will form the basis for the procurement of technologies to be used in a planned experimentation and quality-testing lab.

  • ACCESSWIRE

    ITOCO Signs Agreement with ASOCANNABIS to Develop an Academic Curriculum on the Medical Use of Cannabis

    TORONTO, ON / ACCESSWIRE / August 14, 2019 / ITOCO Inc. ("ITOCO" or the "Company") (OTC PINK:ITMC) today announced that its Colombian subsidiary, ITOCO BIOMED SAS (“ITOCO BIOMED") has signed an agreement (the "Agreement") with the ASOCIACION INTERNACIONAL DE INDUSTRIAS Y CULTIVADORES DEL CANNABIS (ASOCANNABIS) to jointly develop an academic curriculum on the medicinal use of cannabis. Asocannabis is a national guild that oversees the ethical exercise of the medical profession in Colombia. “Developing proper scientific and medical use protocols for health practitioners and patients is critical to sustain the advancement of medical cannabis in Colombia and elsewhere" said Michael Paul, President & CEO of ITOCO Inc.

  • ACCESSWIRE

    ITOCO Signs Letter Of Intent For Hemp Biomass Production With PROHEMP COLOMBIA SAS

    TORONTO, ON / ACCESSWIRE / August 6, 2019 / ITOCO INC. (OTC PINK:ITMC) is pleased to announce it has signed a letter of intent with Hemp biomass producer PROHEMP COLOMBIA SAS (PHC). ITOCO INC and ITOCO ...

  • ACCESSWIRE

    ITOCO Engages Bizlatinhub for Governmental and Commercial Representation in Colombia

    TORONTO, ON / ACCESSWIRE / July 30, 2019 / ITOCO INC. (OTC Pink:ITMC) is pleased to announce it has engaged BizLatinHub (BLH) to assist ITOCO in applying for additional Cannabis licenses in Colombia and ...

  • ACCESSWIRE

    ITOCO Provides Shareholder Update and Comments on Recent Activity

    TORONTO, ON / ACCESSWIRE / July 29, 2019 / ITOCO INC. (“ITOCO” or the “Company) (OTC Pink: ITMC), announces that it has implemented an enhanced shareholder communications program to bring greater transparency into the Company's business plans and growth initiatives. “ITOCO will communicate more effectively with shareholders on an ongoing basis in order to supply pertinent information,” said Michael Paul, CEO of ITOCO. Accurate information about Itoco may be found at www.itoco.net, and through its corporate newsletter.

  • ACCESSWIRE

    ITOCO Biomed Has Sights Set on Acquiring a New Processing Facility in the Colombian Free Trade Zone.

    TORONTO, ON / ACCESSWIRE / July 17, 2019 / ITOCO INC. (OTC Pink: ITMC) is pleased to announce it has engaged Agro Business Group SAS to acquire a new processing facility in the Colombian Free Trade Zone. ...

  • ACCESSWIRE

    ITOCO and Mountain Trading SAS Sign JV to Expand CBD Potential in Colombia

    TORONTO, ON / ACCESSWIRE / July 9, 2019 / ITOCO INC. (OTC Pink: ITMC) is pleased to announce it has executed a Letter of Intent with Mountain Trading SAS for a large-scale cannabis/CBD cultivation and production joint venture in Colombia on a premium 40-hectare site. This will give ITOCO a world class footprint for the processing and production of CBD cannabis derivatives for export into major legal world markets. ITOCO is a 5-year-old publicly quoted specialty CBD medical cannabis development, production and distribution company based in Toronto, Canada and Bogota, Colombia.

  • ACCESSWIRE

    ITOCO - Camedco JV Creates Future Leader in Medical Cannabis

    TORONTO, ON / ACCESSWIRE / February 27, 2019 / Itoco Inc (OTC PINK: ITMC), has signed a letter of intent to form a joint venture with Camedco to be named Itoco Biomed. The project has 18 hectares of licensed land in Colombia for the legal production of medical cannabis and processing for export. This partnership positions Itoco to be a global leader in medical cannabis.